Helical Tomotherapy Planning for Left-Sided Breast Cancer Patients With Positive Lymph Nodes: Comparison to Conventional Multiport Breast Technique

International Journal of Radiation Oncology Biology Physics

Volumn 73, Issue 4, 2009, Pages 1243-1251

  Goddu, S Murty ^a   Chaudhari, Summer ^a   Mamalui Hunter, Maria ^a   Pechenaya, Olga L ^a   Pratt, David ^a   Mutic, Sasa ^a   Zoberi, Imran ^a   Jeswani, Sam ^b   Powell, Simon N ^a,c   Low, Daniel A ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TOMOTHERAPY INC   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Breast cancer; Conventional three dimensional technique; Helical tomotherapy; IMRT; Intensity modulated radiotherapy; Radiotherapy; Treatment planning

Indexed keywords

BIOLOGICAL ORGANS; BODY FLUIDS; PHYSICAL THERAPY; RADIOTHERAPY; THREE DIMENSIONAL;

BREAST CANCER; CONVENTIONAL THREE-DIMENSIONAL TECHNIQUE; HELICAL TOMOTHERAPY; IMRT; INTENSITY-MODULATED RADIOTHERAPY; TREATMENT PLANNING;

TARGETS;

ADVANCED CANCER; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE SEVERITY; FEASIBILITY STUDY; FEMALE; HEART PROTECTION; HUMAN; INTERMETHOD COMPARISON; LUNG; LYMPH NODE; LYMPH NODE METASTASIS; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RADIATION DOSE; THORAX WALL; TOMOTHERAPY; TREATMENT PLANNING;

AXILLA; BREAST; BREAST NEOPLASMS; FEASIBILITY STUDIES; FEMALE; HEART; HUMANS; LUNG; LYMPH NODES; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; THORACIC WALL; TOMOGRAPHY, SPIRAL COMPUTED; TUMOR BURDEN;

EID: 61349186966     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2008.11.004     Document Type: Article

References (35)

1. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
2. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy: Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 337 (1997) 949-955
3. Klein E.E., Taylor M., Michaletz-Lorenz M., et al. A mono isocentric technique for breast and regional nodal therapy using dual asymmetric jaws. Int J Radiat Oncol Biol Phys 28 (1994) 753-760
4. Lichter A.S., Fraass B.A., van de Geijn J., et al. A technique for field matching in primary breast irradiation. Int J Radiat Oncol Biol Phys 9 (1983) 263-270
5. Taylor M.E., Perez C.A., Halverson K.J., et al. Factors influencing cosmetic results after conservation therapy for breast cancer. Int J Radiat Oncol Biol Phys 31 (1995) 753-764
6. Taghian A.G., Assaad S.I., Niemierko A., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 93 (2001) 1806-1811
7. Gagliardi G., Bjohle J., Lax I., et al. Radiation pneumonitis after breast cancer irradiation: Analysis of the complication probability using the relative seriality model. Int J Radiat Oncol Biol Phys 46 (2000) 373-381
8. Wennberg B., Gagliardi G., Sundbom L., et al. Early response of lung in breast cancer irradiation: Radiologic density changes measured by CT and symptomatic radiation pneumonitis. Int J Radiat Oncol Biol Phys 52 (2002) 1196-1206
9. Pierce S.M., Recht A., Lingos T.I., et al. Long-term radiation complications following conservative surgery (CS) and radiation therapy (RT) in patients with early stage breast cancer. Int J Radiat Oncol Biol Phys 23 (1992) 915-923
10. Roychoudhuri R., Robinson D., Putcha V., et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer: A population-based study. BMC Cancer 7 (2007) 9
11. Das S.K., Baydush A.H., Zhou S., et al. Predicting radiotherapy-induced cardiac perfusion defects. Med Phys 32 (2005) 19-27
12. Marks L.B., Yu X., Prosnitz R.G., et al. The incidence and functional consequences of RT-associated cardiac perfusion defects. Int J Radiat Oncol Biol Phys 63 (2005) 214-223
13. Hurkmans C.W., Borger J.H., Bos L.J., et al. Cardiac and lung complication probabilities after breast cancer irradiation. Radiother Oncol 55 (2000) 145-151
14. Kestin L.L., Sharpe M.B., Frazier R.C., et al. Intensity modulation to improve dose uniformity with tangential breast radiotherapy: initial clinical experience. Int J Radiat Oncol Biol Phys 48 (2000) 1559-1568
15. Vicini F.A., Sharpe M., Kestin L., et al. Optimizing breast cancer treatment efficacy with intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 54 (2002) 1336-1344
16. Fogliata A., Nicolini G., Alber M., et al. IMRT for breast: A planning study. Radiother Oncol 76 (2005) 300-310
17. Popescu C.C., Olivotto I., Patenaude V., et al. Inverse-planned, dynamic, multi-beam, intensity-modulated radiation therapy (IMRT): A promising technique when target volume is the left breast and internal mammary lymph nodes. Med Dosim 31 (2006) 283-291
18. Gonzalez V.J., Buchholz D.J., Langen K.M., et al. Evaluation of two tomotherapy-based techniques for the delivery of whole-breast intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 65 (2006) 284-290
19. Bentel G.C. First place 1989 Alpha Cradle Award winner: Positioning and immobilization device for patients receiving radiation therapy for carcinoma of the breast. Med Dosim 15 (1990) 3-6
20. van Asselen B., Raaijmakers C.P., Hofman P., et al. An improved breast irradiation technique using three-dimensional geometrical information and intensity modulation. Radiother Oncol 58 (2001) 341-347
21. Kissick M.W., Fenwick J., James J.A., et al. The helical tomotherapy thread effect. Med Phys 32 (2005) 1414-1423
22. Seppenwoolde Y., Lebesque J.V., de Jaeger K., et al. Comparing different NTCP models that predict the incidence of radiation pneumonitis: Normal tissue complication probability. Int J Radiat Oncol Biol Phys 55 (2003) 724-735
23. Graham M.V., Purdy J.A., Emami B., et al. Clinical dose-volume histogram analysis for pneumonitis after 3D treatment for non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 45 (1999) 323-329
24. Hernando M.L., Marks L.B., Bentel G.C., et al. Radiation-induced pulmonary toxicity: A dose-volume histogram analysis in 201 patients with lung cancer. Int J Radiat Oncol Biol Phys 51 (2001) 650-659
25. Wang S., Liao Z., Wei X., et al. Analysis of clinical and dosimetric factors associated with treatment-related pneumonitis (TRP) in patients with non-small-cell lung cancer (NSCLC) treated with concurrent chemotherapy and three-dimensional conformal radiotherapy (3D-CRT). Int J Radiat Oncol Biol Phys 66 (2006) 1399-1407
26. Krueger E.A., Fraass B.A., McShan D.L., et al. Potential gains for irradiation of chest wall and regional nodes with intensity modulated radiotherapy. Int J Radiat Oncol Biol Phys 56 (2003) 1023-1037
27. Ramsey C.R., Seibert R.M., Robison B., et al. Helical tomotherapy superficial dose measurements. Med Phys 34 (2007) 3286-3293
28. Higgins P.D., Han E.Y., Yuan J.L., et al. Evaluation of surface and superficial dose for head and neck treatments using conventional or intensity-modulated techniques. Phys Med Biol 52 (2007) 1135-1146
29. Minor G.I., Yashar C.M., Spanos Jr. W.J., et al. The relationship of radiation pneumonitis to treated lung volume in breast conservation therapy. Breast J 12 (2006) 48-52
30. Lingos T.I., Recht A., Vicini F., et al. Radiation pneumonitis in breast cancer patients treated with conservative surgery and radiation therapy. Int J Radiat Oncol Biol Phys 21 (1991) 355-360
31. Campone M., Fumoleau P., Bourbouloux E., et al. Taxanes in adjuvant breast cancer setting: which standard in Europe?. Crit Rev Oncol Hematol 55 (2005) 167-175
32. Giordano S.H., Duan Z., Kuo Y.F., et al. Impact of a scientific presentation on community treatment patterns for primary breast cancer. J Natl Cancer Inst 98 (2006) 382-388
33. Taghian A.G., Assaad S.I., Niemierko A., et al. Is a reduction in radiation lung volume and dose necessary with paclitaxel chemotherapy for node-positive breast cancer?. Int J Radiat Oncol Biol Phys 62 (2005) 386-391
34. Hojris I., Overgaard M., Christensen J.J., et al., Radiotherapy Committee of the Danish Breast Cancer Cooperative Group. Morbidity and mortality of ischaemic heart disease in high-risk breast-cancer patients after adjuvant postmastectomy systemic treatment with or without radiotherapy: Analysis of DBCG 82b and 82c randomised trials. Lancet 354 (1999) 1425-1430
35. Boice Jr. J.D., Harvey E.B., Blettner M., et al. Cancer in the contralateral breast after radiotherapy for breast cancer. N Engl J Med 326 (1992) 1243-1251